Skip to main content

06-25 02 58 98

Auteur: Astrid Potjes

7e Limburgs Hartfalen Symposium

Geschreven door Astrid Potjes op . Gepost in Komende congressen.

Op deze pagina vindt u informatie over een afgerond symposium waar DOEN congressen en evenementen werk van heeft gemaakt. Heeft u interesse om een congres of evenement te organiseren? Neemt u dan contact met ons op, we bespreken graag alle mogelijkheden met u. 

7e Limburgs Hartfalen Symposium

Op dinsdag 1 oktober 2024 vond het 7e Limburgs Hartfalen Symposium plaats in het Van der Valk Hotel Stein-Urmond. De innovatie binnen hartfalen gaat razendsnel, met nieuwe richtlijnen, nieuwe wetenschappelijke inzichten en meerdere behandelopties.

Onder voorzitterschap van dr. A.M.W. van Stipdonk presenteerden collega’s uit de regio een onderwerp aan de hand van een interactieve casus over ‘een gedecompenseerde patiënt met nieuw HFrEF’. Daarbij was voldoende ruimte voor interactie en discussie tussen sprekers en deelnemers.

Datum
Dinsdag 01 oktober 2024

Locatie
Van der Valk Hotel Stein-Urmond
Mauritslaan 65
6129 EL Urmond

Accreditatie
Geaccrediteerd door de NVVC, het VSR en de NAPA voor 3 punten.

Doelgroep
Cardiologen, cardiologen in opleiding, verpleegkundig specialisten en physician assistants.

Kosten
Voor deelnemers waren er geen deelnamekosten verbonden aan deze nascholing.

Klik op onderstaand icoon om de flyer over deze avond te bekijken.

[file-pdf]

programma

  • 18:00 uur

    Ontvangst, registratie en buffet

  • 18:50 uur

    Welkom en opening door de voorzitter
    Dr. A.M.W. van Stipdonk

  • 19:00 uur

    Introductie casus: ‘gedecompenseerde patiënt met nieuw HFrEF’
    Dr. A.M.W. van Stipdonk, cardioloog, MUMC+, Maastricht

  • 19:10 uur

    Zorgpad acute decompensatio cordis
    Dr. S. Sanders-van Wijk, cardioloog, Zuyderland MC, Heerlen-Sittard/Geleen

  • 19:40 uur

    Nierfunctieproblemen en HFrEF – acuut en chronisch
    Dr. J.G. Meeder, cardioloog, VieCuri, Venlo

  • 20:10 uur

    Koffiepauze en dessert

  • 20:30 uur

    Onderzoek de oorzaak van hartfalen – CAG/revascularisatie bij HFrEF?
    Pro: Dr. A. Lux, cardioloog, MUMC+, Maastricht
    Contra: Dr. M.R. Hazebroek, cardioloog, Zuyderland MC, Heerlen

  • 21:00 uur

    Ontslag & vervolg optitratiepoli
    L.C.S. Roost, verpleegkundig specialist, VieCuri MC, Venlo

  • 21:30 uur

    Titrate-HF
    Dr. A.M.W. van Stipdonk, cardioloog, MUMC+, Maastricht

  • 21:45 uur

    Afsluiting
    Dr. A.M.W. van Stipdonk

  • 21:50 uur

    Einde 7e Limburgs Hartfalen Symposium

Deze nascholingscursus werd mede mogelijk gemaakt door:



Lees verder

Cardiologie Symposium Zuidwest-Nederland

Geschreven door Astrid Potjes op . Gepost in Komende congressen.

Op deze pagina vindt u informatie over een congres dat DOEN congressen en evenementen georganiseerd heeft. Bent u benieuwd wat wij voor kunnen DOEN, neem dan contact met ons op.  

Cardiologie Symposium Zuidwest-Nederland

Op 6 juni 2024 werd het Cardiologie Symposium Zuidwest-Nederland in Breda georganiseerd. 

Onder leiding van Dr. I.R. Henkens presenteerden vier collega’s deels aan de hand van casuïstiek hun kennis en wetenschappelijke ontwikkelingen. Daarbij werd er gezorgd voor voldoende ruimte voor interactie en discussie tussen sprekers en deelnemers.

Datum
Donderdag 6 juni 2024

Locatie
Van der Valk Hotel Breda
Princenhagelaan 5
4813 DA Breda

Accreditatie
Geaccrediteerd door de NVVC en de NAPA voor 3 punten.
Door de VSR voor 2 punten.

Doelgroep
Cardiologen (i.o.), verpleegkundig specialisten en physician assistants.

Kosten
Er zijn voor u geen deelnamekosten verbonden aan deze nascholing.

Klik op onderstaand icoon om de flyer over deze avond te bekijken.

[file-pdf]

Programma

  • 18:00 uur

    Ontvangst, registratie en buffet

  • 18:45 uur

    Welkom en inleiding door de voorzitter
    Dr. I.R. Henkens, cardioloog, Bravis Ziekenhuis, Roosendaal

  • 19:00 uur

    Cardio-Psychologie
    Prof. dr. J.W.M.G. Widdershoven, cardioloog, ETZ Tweesteden, Tilburg

  • 19:30 uur

    Hartfalen en devices
    Drs. M.W.F. van Gent, cardioloog, ASZ, Dordrecht

  • 20:00 uur

    Pauze

  • 20:15 uur

    Imaging met casuïstiek
    Drs. T. Springeling, cardioloog, Rivas Beatrixziekenhuis, Gorinchem

  • 20:45 uur

    Palliatieve zorg
    Dr. K. Boerlage, cardioloog, JBZ, ‘s-Hertogenbosch

  • 21:15 uur

    Afsluiting door de voorzitter
    Dr. I.R. Henkens

  • 21:30 uur

    Einde Cardiologie Symposium Zuidwest-Nederland

Deze nascholingscursus werd mede mogelijk gemaakt door:



Lees verder

Programma Hybride Ontmoetingsdag Amyloïdose 2024

Geschreven door Astrid Potjes op . Gepost in Programma.

Op deze pagina vindt u informatie over een congres dat DOEN congressen en evenementen georganiseerd heeft. Bent u benieuwd wat wij voor kunnen DOEN, neem dan contact met ons op.  

Hybride Ontmoetingsdag Amyloïdose 2024

Op zaterdag 8 juni 2024 organiseerde Stichting Amyloïdose Nederland weer de jaarlijkse Ontmoetingsdag voor patiënten met amyloïdose, hun naasten, medici en andere geïnteresseerden.
Ook dit jaar was de plaats van samenkomst in Nijkerk. Een deel van het programma was ook online bij te wonen.
Onderstaand vindt u het programma van deze dag. 

Datum
Zaterdag 8 juni 2024

Locatie
Vergader en congrescentrum De Schakel
Oranjelaan 10
3862 CX Nijkerk

Online
Deze bijeenkomst was ook online bij te wonen. Wij voorzagen deelnemers na inschrijving van een link.

Doelgroep
Patiënten met amyloïdose, hun naasten, medici en andere geïnteresseerden.

Focusgroep
In het inschrijfformulier kunt u uit verschillende groepen lotgenotencontact kiezen, daar staat ook de keuze voor twee focusgroepen bij. 
Focusgroep ATTR: de periode voordat u de diagnose kreeg, klik hier voor meer informatie. 
Focusgroep ATTR: de periode nadat u de diagnose kreeg, klik hier voor meer informatie.

Presentatie video’s sprekers
Als voorbereiding konden deelnemers alvast naar onderstaande video’s kijken waarin de sprekers van deze dag een presentatie geven. Vragen konden vervolgens ingediend worden. 

Presentatie  ATTR Amyloïdose
Dr. Hans Nienhuis, internist-allergoloog/immunoloog, UMC Groningen

Presentatie AL amyloïdose
Prof.dr. Monique Minnema, internist-hematoloog, UMC Utrecht

programma

  • 10:00 – 10:30 uur

    Ontvangst met koffie en thee in De Schakel Nijkerk

  • 10:30 – 10:40 uur

    Welkom door John Rusman, bestuur Amyloïdose Nederland

  • 10:40 – 10:45 uur

    Oprichting van en samenwerking met Amybel, Guy Lippens, Amyloïdose België

  • 10:45 – 10:55 uur

    Wisselen van zaal voor deelnemers aan ATTR presentatie

  • 10:55 – 11:40 uur

    ATTR amyloïdose, update van de laatste ontwikkelingen en beantwoorden van vragen
    Dr. Hans Nienhuis, internist-allergoloog/immunoloog, UMC Groningen

  • 10:55 – 11:40 uur

    AL amyloïdose, update van de laatste ontwikkelingen en beantwoorden van vragen
    Prof.dr. Monique Minnema, internist-hematoloog, UMC Utrecht

  • 11:40 – 11:50 uur

    Deelnemers van ATTR presentatie gaan terug naar plenaire zaal

  • 11:50 – 12:35 uur

    Ontwikkelingen bij nierproblemen en beantwoorden van vragen
    Dr. Alferso Abrahams, internist-nefroloog, UMC Utrecht

  • 12:35 – 14:00 uur

    Lunchpauze voor de deelnemers in Nijkerk en tijd voor ontmoeting

  • 14:00 – 15:00 uur

    Lotgenotencontact (niet online te volgen)
    Deelnemers kunnen ervaringen delen met lotgenoten.
    Dit gebeurt in groepen van max. 15 personen.

  • 15:00 – 16:00 uur

    Gelegenheid tot napraten onder het genot van een hapje en drankje.

Lees verder

accommodation & registration

Geschreven door Astrid Potjes op . Gepost in Info tickets.

The meeting, accommodation, breakfasts, lunches and (most of the) dinners are in Hotel Noordsee.

The meeting fee
The meeting fee consists of the fixed registration fee of € 350,- and the room rate.
The room rate is variable and depends on the option you choose; you can book a room for single use or share a room/studio with one other person.
The registration fee will automatically be added to the roomrate after your choice of the room/studio (bottom of this page)

Payment
You can pay via ideal, bancontact or via banktransfer.

Registration terms and conditions

  • After registration, your participation is confirmed and final.
  • After March 15, 2024, the meeting fee is not refundable. Substitutions are always accepted.
  • You will receive an email from us with further information about travel options to Holwerd, from where we will take the ferry to Ameland.
  • The meeting fee covers your program participation, all the meals and coffee breaks, local sight-seeing tour, the transfer with a chartered ferry from main land (port Holwerd) to the island of Ameland (Nes) on April 19 at 3.00 PM and return on April 23 at 09.00 AM., bus transfer from train station Leeuwarden to harbor of Holwerd on April 19 at 2.00 PM and on April 23 at 10.10 AM, bus trips on the island.
  • When you check-in at the hotel, you receive 12 coins for drinks during dinner for the 4 nights.
  • All f&b outside the conference program in the hotel, the bar or outside the hotel are at your own expense. For drinks in the hotel, you can pay cash/payment card.
  • When you decide to come to Ameland on different times as mentioned above, cost of transportation are at your own expense.

Insurance
It is the responsibility of the attendee to arrange appropriate insurance cover in connection with their attendance at the conference.
DOEN congressen en evenementen cannot be held liable for any loss, liability or damage to personal property.

Practical travelling information
Please download this form and fill in your travel information. You can return it by mail to secretariaat@doen-congressen.nl

Room/studio
We have made room reservations in Hotel Noordsee for the whole group. In below overview you find the several rates for the different rooms/studio’s. Please add your choice in de dropdown overview below, to book your room.
If you want to share a room, please fill in the name of that person in the appropriate field on the registration form. The person with whom you share a room with also makes her/his own registration via the website and fills in your name in the field.

If you are travelling alone and don’t have a roommate, please let us know if you would like to share a studio with another conference participant who’s also travelling alone. We can connect the two of you.
Please send an email to secretariaat@doen-congressen.nl

If you are working for the pharmaceutical industry and would like to participate you can contact us for the possibilities via info@doen-congressen.nl

A. Room single use, one kingsize bed, € 640,- for 4 nights
B. Twinbed room, double use: 2 seperate beds, 10 cm  in between € 360,00 p.p. for 4 nights
C. Studio double use: kingsize/twinbed or bed in separate room. The Studio has a kitchenette. €440,00 p.p. for 4 nights
D. Studio double use: kingsize/twinbed with bunkbed in separate room. The Studio has a kitchenette. € 440,00 p.p. for 4 nights
E. Studio: bunkbed in separate bedroom in studio D. € 320,- p.p. for 4 nights

Program 25th Meeting of the European Red Cell Society

Geschreven door Astrid Potjes op . Gepost in Programma.

On this page you will find the program of the 25th Meeting of the European Red Cell Society that DOEN congresses and events has organized. If you would like to have more information about the meeting or to know more about what we can do for you, please contact us via info@doencongressen.nl or call +31 (0)6 25025898  We are happy to assist you and to answer any question you may have.

program

the 25th Meeting of the European Red Cell Society

From April 19-23, 2024 we have organized the 25th meeting of the European Red Cell Society. The meeting was held at Hotel Noordsee, Ameland, the Netherlands.

This biannual International meeting attracts leading experts in the fields of erythropoiesis, red blood cell physiology and function, and red blood cell related disorders. It is an event that brings together 100+ people from Europe and beyond, and connects the fields of research, diagnostics and clinical implications. The target audience are researchers (basic and translational), laboratory specialists, hematologists, and PhD students.

Organizing committee
 The content of this 4 day course is the responsibility of the organizing committee, consisting of:

  • Dr. Emile van den Akker, dr. Robin van Bruggen, and dr. Marieke von Lindern (Sanquin, Amsterdam, The Netherlands)

  • Dr. Kees Harteveld (Leiden University Medical Center, Leiden, The Netherlands)

  • Dr. Marije Bartels, dr. Minke Rab, dr. Richard van Wijk (University Medical Center Utrecht, Utrecht, The Netherlands)

Friday, April 19

  • 15:00 – 16:00

    Outward journey Holwerd-Nes

  • 16:45 – 17:30

    • Check-in hotel

  • 18:30 – 19:30

    Cell cycle structure and speed in erythroid development and the response to erythroid stress
    Merav Socolovsky, Professor UMASS Chan Medical School, United States

  • 19:30 – 21:30

    Buffet dinner

Saturday, April 20

07:30 – 08:45

Breakfast

Scientific session 1 – Erythropoiesies

Chairs:  Wassim el Nemer / Catarina Freire 

  • 09:00 – 09:30

    Erythromyeloblastic Islands
    Lionel Blanc, Northwell, United States

  • 09:30 – 09:45

    Anemia links β-catenin with FOXO3 signaling during erythroid terminal differentiation
    Santhe van der Meulen, Sanquin, the Netherlands

  • 09:45 – 10:00

    In vitro culture of erythroblasts (EBL) and production of mature erythrocytes for transfusions requires upscaling in fluidic-turbulent systems
    Giulia Iacono, Sanquin, the Netherlands

  • 10:00 – 10:15

    The Role of the Zcchc6/Dis3L2 RNA Editor-Exonuclease Axis in Terminal Erythroid Differentiation
    Areum Han, Harvard Medical school / Boston’s Children Hospital, United States

  • 10:15 – 10:30

    Transfusion-ready red blood cell generation from induced pluripoten stem cells (iPSCs)
    Emile van den Akker    , Sanquin, the Netherlands

  • 10:30 – 10:45

    Detailed characterization of iPSC-derived hematopoiesis and erythropoiesis en self-organized cellular complexes (hemanoids)
    Isabel Dorn, Medical University Graz, Austria

10:45 – 11:15

Coffee break

Scientific session 2 – Ion channels of the red blood cell – function and disorders

Chairs: Giampaolo Minetti /  Silvia Neri

  • 11:15 – 11:45

    Defects of RBC cell volume regulation and hydration state: their pathophysiology and diagnosis
    Paola Bianchi, Fondazione IRCCS Ca’ Granda Policlinico Milan, Italy

  • 11:45 – 12:00

    Electrophysiological characterization of red blood cells using the automated patch clamp
    Nicoletta Muarciano, Nanion Technologies, Germany

  • 12:00 – 12:15

    Role of Piezo 1 in terminal density reversal of healthy red blood cells
    Kuntal Dey, University of Zurich, Switserland

  • 12:15 – 12:30

    Red Blood Cell Protein contribution to Malaria Parasite Invasion. Basigin mediation of Plasmodium falciparum red blood cell invasion does not require its transmembrane domain or interaction with monocarboxylate transporter
    Timothy Satchwell, University Bristol, UK

  • 12:30

    Lunch

  • Networking session

  • Poster presentations – titles and authors can be found below this program

  • ‘Meet the expert’ session with Ingolf Bernhardt
    Unsolved problems in red cell research
    Ingolf Bernhardt, University     Saarland, Germany

Scientific session 3 – Red blood cell membrane and associated disorders  & 4. Clinical hematology – new treatments in sickle cell disease and other hereditary red blood cell disorders

Chairs: Stephane Egee / Min Qiao

Red blood cell membrane and associated disorders

  • 16:00 – 16:30

    Membranopathies : from cytology and red cell/reticulocyte indices to molecular diagnosis, including prenatal diagnosis
    Lydie da Costa, University Paris, France

  • 16:30 – 16:45

    Developmental changes in membrane lipid composition during terminal maturation of circulating human reticulocytes and ageing of red cells
    Giampaolo Minetti, University of Pavia, Italy

  • 16:45 – 17:00

    Modulation of terminal erythropoiesis by a TSPO ligand
    Alice Dussouchaud, Inserm, France

  • 17:00 – 17:15

    Complete absence of GLUT1 does not impair human terminal erythroid differentiation
    Catarina Freire, University of Bristol, United Kingdom

  • 17:15 – 17:30

    Dual action of Dooku1 on PIEZO1 channel in human red blood cells
    Guillaume Bouyer, CNRS, France

Clinical hematology – new treatments in sickle cell disease and other hereditary red blood cell disorders

17:30 – 17:45

Single center report of hemoglobinopathy free survival after pediatric hematopoietic stem cell transplantation
Gertjan Lugthart, pediatrician, LUMC, Leiden, the Netherlands

18:45 – 22:00

Dinner

Sunday, April 21

07:30 – 08:45

  • Breakfast

Scientific session 4 – Clinical hematology – new treatments in sickle cell disease and other hereditary red blood cell disorders

Chairs: Sjaak Philipsen / Marissa Traets

  • 09:00 – 09:30

    Curative approaches for patients with sickle cell disease
    Erfan Nur, Amsterdam UMC, the Netherlands

  • 09:30 – 09:45

    Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling
    Nicolas Hebert, Etablissement Francais Du Sand, France

  • 09:45 – 10:00

    Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease
    Myrthe van Dijk,     UMC Utrecht, the Netherlands

  • 10:00 – 10:15

    Plasma Proteome Profiling of Sickle Cell Patients Reveals Activation of Inflammatory Pathways During Steady State and Vaso-occlusive Crisis
    Lydian de Ligt, Amsterdam UMC, the Netherlands

  • 10:15 – 10:30

    Red cell rheology and blood viscosity in individuals with sickle cell disease following allogenic bone marrow transplantation or autologous gene addition therapy
    Vivien Sheehan, Emory University of Medicine, United States

  • 10:30 – 10:45

    A novel allosteric activator of pyruvate kinase enhances human and mouse enzymatic activity and leads to ematological improvements in sickle cell disease mouse models
    Carsten Alt, Pfizer

10:45 – 11:15

Coffee break

Scientific session 5 – Disorders of Erythropoiesies

Chairs: Tim Satchwell / Carolina Hernandez

  • 11:15 – 11:45

    Patient-specific cell lines to study erythropoiesis and hemoglobin switching
    Sjaak Philipsen, Erasmus MC Rotterdam, the Netherlands

  • 11:45 – 12:00

    Ineffective erythropoiesis negatively impacts the erythroblastic island in sickle cell disease
    Wassim El Nemer, EFS Sante, France

  • 12:00 – 12:15

    Anemia in aged mice is accompanied by reduced erythroid lineage cell production and increased red blood cell life span
    Carsten Alt, Pfizer, United States

  • 12:15 – 12:30

    Development of a beta-thalassemia rat model for bone marrow characterization after stem cell transplantation
    Karolin Roemhild, Sanquin, the Netherlands

  • 12:30 – 12:45

    Elucidating glucocorticoid-responsiveness in Diamond-Blackfan anemia syndrome using iPSC-derived erythroblasts
    Teun Slijkerman, Sanquin, the Netherlands

Sponsored session

  • 12:45 – 13:00

    Lorrca Developments
    Presentation by Pim Brandjes, RR Mechatronics

  • 13:00 – 13:15

    RoxyScan: a novel method to evaluate red blood cell resilience to oxidative stress exposure in Sickle Cell disease
    Carolina Hernandez, University Medical Center Utrecht, The Netherlands

  • 13:15 – 13:30

    Getinge

13:30 – 14:15

Lunch

14:30 – 18:00

Network session

19:00 – 22:00

Dinner

Monday, April 22

07:30 – 08:45

  • Breakfast

Scientific session 6 – New developments for red cell research  and diagnostics

Chairs: Paola Bianchi / Jonathan de Wilde

  • 09:00 – 09:30

    Probing red blood cells’s bio-mechanical properties
    Lars Kaestner, University of Saarland, Germany

  • 09:30 – 09:45

    An Efficient and Specific Reporter System Suitable for High-Throughput Screening of Novel Fetal Hemoglobin Inducers
    Tingyue Li, ErasmusMC,      Rotterdam, the Netherlands

  • 09:45 – 10:00

    Pyruvate Kinase Thermostability Is Associated with Red Blood Cell Adhesion, Deformability and Oxygen Affinity in Patients with Sickle Cell Disease
    Marissa Traets, UMC Utrecht, the Netherlands

  • 10:00 – 10:15

    Towards quantification of intracellular free calcium in individual red blood cells by fluorescence lifetime imaging microscopy
    Min Qiao, Saarland University, Germany

  • 10:15 – 10:30

    Ex vivo glycolytic flux measurements in red blood cells
    Titine Ruiter, UMC Utrecht, the Netherlands

  • 10:30 – 10:45

    Hepatic Leukemia Factor as a marker for iPSC – derived Hematopoietic Stem Cells
    Maria Simanovich, Erasmus MC Rotterdam, the Netherlands

10:45 – 11:15

Coffee break

Scientific session 7 – New developments for red cell research and diagnostics & 6. New developments for red cell research and diagnostics

Chairs: Lars Kaestner / Giulia Iacono

Clinical cases

11:15 – 11:45

SUPT5H nonsense variants as modifying factor in beta-thalassemia trait
Kees Harteveld, Leiden University MC, The Netherlands

New developments for red cell research and diagnostics

  • 11:45 – 12:00

    An AI-based imaging flow cytometry approach to study erythrophagocytosis
    Silvia Neri, Sanquin, the Netherlands

  • 12:00 – 12:15

    Endothelialized 3D perfusion model to study ex vivo reticulocyte-to-erythrocyte transition
    Claudia Maria Bernecker, University of Graz, Austria

  • 12:15 – 12:30

    Actomyosin-driven expulsion of hemoglobin during hemolysis,
    Tessa Korsa, Fraunhofer IBMT, Sulzbach, Germany

  • 12:30 – 12:45

    Red cell function devices under development for use in sickle cell disease
    Vivien Sheehan, Emory University School of Medicine, Atlanta, United States

12:45 – 13:45

Lunch

Scientific session 8 – Clinical hematology – new diagnostic approaches & 2. Ion Channels

Chairs: Vivian Sheehan / Myrthe van Dijk

  • 13:45 – 14:15

    Biomarkers in sickle cell disease
    Minke Rab, UMC Utrecht, The Netherlands

  • 14:15 – 14:30

    Novel direct plasma heme-related assay decyphers hemolytic anemia and ineffective erythropoiesis
    Nicolas Hebert, Etablissement Francais Du Sang IDF, France

  • 14:30 – 14:45

    Impact of Sickle Cell Disease Patients-Derived Red Blood Cells on Clot Dynamics and Fibrin Structure
    Naoual Ouazzani Chahdi, Sanquin, the Netherlands

  • 14:45 – 15:00

    Low Voxelotor Concentrations Exacerbate Sickle Cell Formation At Low Oxygen Pressure
    Emile van den Akker, Sanquin, the Netherlands

  • 15:00 – 15:15

    Soluble Transferrin Receptor as a Marker for Assessing Disease Severity in  Hereditary Hemolytic Anemias
    Geoffrey Kuppens, UMC Utrecht, the Netherlands
    Presented by Marije Bartels, UMC Utrecht, the Netherlands

  • 15:15 – 15:30

    Autoimmune hemolytic anemia anti-RBC IgM, but not IgG, drive in vitro complement activation
    Femke Mulder, Sanquin, the Netherlands

Ion Channels

15:30 – 15:45

Ion channels of the red blood cell:
Effects of Pyruvate Kinase Activation in Hereditary Hemolytic Anemia
Jonathan de Wilde, UMC Utrecht, the Netherlands

  • 15:45 – 16:15

    Coffee break, followed by sessions:

  • 15:45 – 16:45

    Poster presentations – titles and authors can be found under this program

  • 15:45 – 17:00

    Steering Committee meeting on the consensus-based Recommendation for the Diagnosis of Rare Hemolytic Anemia
    Sponsored by EuroBloodNet

  • 17:00 – 17:45

    ERCS General Assembly meeting 

  • 18:30 – 21:30

    Dinner

Tuesday, April 23

  • 07:00 – 08:00

    Breakfast and checkout, payment of expenses (bar)

  • 08:30

    Departure from hotel by bus to harbor

  • 09:00

    Departure by ferry ‘Brakzand’ to mainland

Posters, format A0, portrait

  • Pseudo Action Potentials (PAPs) in red blood cells – an approach of understanding
    Lars Kaestner, University of Saarland, Germany

  • Anemia in aged mice is accompanied by reduced erythroid lineage cell production and increased red blood cell life span
    Carsten Alt, Pfizer

  • A novel allosteric activator of pyruvate kinase enhances human and mouse enzymatic activity and leads to hematological improvements in sickle cell disease mouse models
    Carsten Alt, Pfizer

  • Can the emergence of cation channel activity during storage threaten the survival of transfused red blood cells?
    Stephane Egee, CNRS, France

  • Cell Therapy Scale-up: Bioprocess Development for the Production of Hematopoietic Cells
    Brenda Juarez Garza, Delft University, the Netherlands

  • The quality of red blood cells isolated from cord blood during storage
    Joyce Bestebroer, Sanquin, the Netherlands

  • Variability of extracellular particle content in red blood cell concentrates upon storage is associated with differential membrane alterations and could be used as quality control
    Donatienne Tyteca, UC Louvain, Belgium

  • Hemoglobin as a multifunctional sensor and buffer
    Anna Bogdanova, University of Zurich, Switzerland

  • Scale-up of stem cell cultures from shake flask to bioreactor: a CFD-based comparison of hydrodynamic stress
    Ramon van Valderen, Delft University, the Netherlands

  • Towards an improved erythroid production from IPSC
    Marien van der Stel, Sanquin, the Netherlands

  • Investigating the Role of Shear Stress on Endothelial-to-Hematopoietic Transitioning
    Oyishee Ahmad, Sanquin, the Netherlands

  • A clinical mechanical marker of red blood cell deformability: sickle cell disease example
    Cecile Jebane, CNRS-CINam, Marseille,     France

  • RBC delivered antigens for the induction of antigen specific immune tolerance,
    Youmna Al Halabi, Sanquin, the Netherlands

This conference is sponsored by








Lees verder

Cookies
DOEN congressen en evenementen gebruikt analytische cookies om u een optimale gebruikerservaring te bieden en functionele cookies zodat u zich bij ons kunt inschrijven voor congressen en symposia. Uw gegevens worden niet gebruikt of opgeslagen voor andere doeleinden. Lees ons privacybeleid
Instellingen Alles accepteren
Cookies
Kies welke cookies u accepteert. Uw keuze wordt 1 jaar opgeslagen. Lees ons privacybeleid
Opslaan Alles accepteren